基托桑及其衍生物的抗肥胖作用
Balzhima Shagdarova1, Mariya Konovalova2, Valery Varlamov1
1Research Center of Biotechnology, Russian Academy of Sciences, 119071 Moscow, Russia.
Polymers
|October 14, 2023
概括
奇托及其衍生物通过改善肠道健康和新陈代谢,显示出对控制肥胖的潜力. 它们的花剂特性可能是减少食物吸收和帮助体重管理的关键.
科学领域:
- 生物化学 生物化学
- 药理学 药理学是指药理学的学科.
- 营养科学 营养科学
背景情况:
- 全球肥胖率的上升需要新的治疗策略.
- 酸盐及其衍生物 (如COS) 具有有益的代谢特性.
- 目前的奇托桑疗效是温和的,促使人们对潜在机制进行调查.
研究的目的:
- 审查基托,COS和衍生物的抗肥胖作用.
- 探索它们的作用机制和结构-活动关系.
- 评估它们在治疗代谢障碍方面的潜力.
主要方法:
- 关于酸盐和肥胖的研究的文献综述.
- 对动物和临床试验数据的分析.
- 检查化学修饰及其对疗效的影响.
主要成果:
- 奇托桑可以改善肠道微生物群,肠道屏障,热生成和脂质代谢.
- 衍生品显示增强的溶解性和潜在的治疗价值.
- 假设的花剂特性作为一种主要的抗肥胖机制.
结论:
- 酸盐和衍生品为肥胖管理提供了一个有前途的自然方法.
- 了解结构-活动关系可以优化治疗潜力.
- 对花剂性质的进一步研究可能会增强抗肥胖策略.
相关概念视频
Oral Hypoglycemic Agents: α-Glucosidase Inhibitors
185
α-glucosidase inhibitors, including acarbose (Precose), miglitol (Glyset), and voglibose (Voglib) (primarily available in Asia), are drugs that control blood sugar levels by delaying the digestion of starch and disaccharides. They achieve this by inhibiting α-glucosidase enzymes in the intestine, which slow the absorption of carbohydrates in the intestine, which in turn leads to a prolonged release of the glucoregulatory hormone GLP-1 from intestinal L-cells.
Acarbose and miglitol are...
Acarbose and miglitol are...
185
Cholesterol: Significance and Regulation
560
Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Considering cholesterol and...
560
Oral Hypoglycemic Agents: Biguanides and Glitazones
212
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
212
Obesity
511
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
511
Hormonal Regulation
43.6K
Hormones regulate a significant portion of digestion through activation of the neuroendocrine system. The neuroendocrine system of digestion contains many different hormones all with multiple functions that are both, directly and indirectly, involved in digestion.
43.6K
Glucagon-like Receptor Agonists
334
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
334


